Ali Asif 4
4 · Protagonist Therapeutics, Inc · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Ali Asif
Chief Financial Officer
Transactions
- Award
Common Stock
2025-01-02+31,779→ 66,739 total - Award
Stock Option (right to buy)
2025-01-02+38,520→ 38,520 totalExercise: $38.98Exp: 2035-01-02→ Common Stock (38,520 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units payable solely in common stock that will vest in four equal annual installments on January 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
- [F2]The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.